Market Opportunities in Cytokine & Growth Factor Research

Although cytokines and growth factors have been studied for many years, this research is taking on greater significance today because the completed sequence of the human genome has revealed a variety of potential new drug targets that are related to previously characterized cytokines, growth factors and receptors. Moreover, the molecules are appearing more and more frequently in the drug development pipelines of biotechnology and pharmaceutical companies. The increasing importance of cytokine and growth factor research has attracted many life science suppliers, both large retailers as well as niche vendors, who are competing for a share of this attractive market. Whether your company sells products for basic research, diagnostics or therapeutics, this report provides valuable information on market dynamics and user needs that will help your business to stay ahead of the curve. Based on an in-depth 30-question survey of over 660 life scientists, this report identifies preferred quantification and activity assays, new research trends and the most popular suppliers of antibodies, recombinant proteins and DNA microarrays.

The major objectives of this report are as follows:

> Determine the scientific objectives of cytokine and growth factor researchers.

> Identify the systems and methodologies that are commonly used in cytokine and growth factor research.

> Ascertain the attributes of reagents and products for cytokine and growth factor research that are considered most important by end users.

> Assess levels of satisfaction with currently available products and reagents for cytokine and growth factor research.

> Identify unmet product needs in the cytokine and growth factor market.

> Determine current and projected throughput levels for key product categories.

Report Highlights

Market Opportunities in Cytokine & Growth Factor Research contains over 75 charts and/or tables and over 25 cross-tabulations for the 30 survey questions.  Below is a glimpse of the key findings derived from just a few of the survey questions:

"           The majority of respondents cited "basic research on biological processes" (67%) as the primary research application in which they use or assay cytokines. (Question 3)

"           When using cell-based or protein-based cytokine assays, respondents most often cited problems or limitations with the "price of assays and/or reagents" (64%) and "low signal-to-noise" (32%).  (Question 10)

"           R&D Systems, Amersham Biosciences and BD Biosciences Clontech were most frequently cited as the respondents' primary supplier of immunoassay kits and reagents.  (Question 15)

"           Respondents were least satisfied with the "price" of antibodies and their "use with fixed iissues."  (Question 16)

"           41% of the respondents project that the number of DNA microarrays they use in their cytokine research will increase, with 38% expecting an increase of 20-39%. (Question 25)

"           Only 4% of the respondents are "very satisfied" with the DNA microarray they use for cytokine assays. (Question 28)

May 2003 Pages: 170 

Publisher: BioInformatics 

To order go to this URL: http://www.bioportfolio.com/cgi-bin/acatalog/copy_of_bioinformatics_1.html#a43